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MinireviewTransducing the Hedgehog Signal
ates Ptc from Smo (Figure 1B) is also generally enter-Daniel Kalderon*
tained (Chen and Struhl, 1996) because it is counteredDepartment of Biological Sciences
only by a single observation of Ptc-mediated binding ofColumbia University
Hh to Smo in tissue culture cells that expressed highNew York, New York 10027
levels of both vertebrate Ptc and Smo (Stone et al.,
1996). Some new data support the idea that active Smo
protein is not in a complex with Ptc following Hh stimula-
Members of the Hedgehog (Hh) family of secreted sig- tion (Figure 1B) and can even be interpreted to suggest
naling molecules direct an enormous variety of develop- that Ptc can repress Smo activity without directly con-
mental events in vertebrates and in Drosophila. To fulfill tacting Smo (Figure 1C). The first new observation is
these roles, both the distribution of Hh molecules and that antibodies directed either to amino- or carboxy-
the response of cells to Hh must be tightly regulated. A terminal regions of the Smo protein show dramatically
good deal is known about the mechanisms that deter- enhanced staining in cells that either lack Ptc activity
mine which cells make Hh in Drosophila, and some fasci- or are exposed to Hh, while smo RNA levels remain
nating observations are prompting ideas about how Hh unchanged (Alcedo et al., 2000; Denef et al., 2000; Ing-
is transported between cells (McMahon, 2000). Our un- ham et al., 2000). There is, however, some disagreement
derstanding of the mechanism of Hh signal transduction about what the newly reported Smo staining pattern
is more fragmentary (Ingham, 1998). Patched (Ptc) is the represents. All three groups constructed a smo trans-
direct receptor for Hh, but Ptc actively silences intracel- gene with a carboxy-terminal epitope tag and examined
lular signaling in the absence of Hh. A second transmem- whether Hh modifies the epitope tag staining pattern
brane protein, Smoothened (Smo), can bind to Ptc but posttranscriptionally. In two studies, epitope tag stain-
not to Hh, and is essential for signal transduction elicited ing mirrored Smo antibody staining, supporting the hy-
either by Hh or by mutational inactivation of Ptc. Thus, pothesis that Hh signaling increases Smo protein levels.
Hh binding to Ptc is thought to activate Smo by abrogat- This was the first indication that Smo might accumulate
ing an otherwise repressive influence of Ptc (Figure 1). in excess of Ptc, and therefore free of Ptc, during Hh
Hh signaling regulates the transcription of several tis- signaling. However, Ingham et al. report a different re-
sue-specific target genes, mediated principally, if not sult—carboxy epitope tag staining and staining of a dif-
entirely, by the transcription factor Cubitus interruptus ferent epitope tag appended to the amino terminus of
(Ci). Ci activity is regulated in many ways (Aza-Blanc Smo were both largely unaffected by Hh signaling. Ing-
and Kornberg, 1999). In the absence of Hh, full-length ham et al. therefore concluded that Hh signaling does
Ci (Ci-155) is partially proteolyzed to a form (Ci-75) that not increase Smo protein levels but leads instead to a
acts as a transcriptional repressor. Hh signaling pre- conformational change in Smo that allows better recog-
vents this proteolysis and also increases the proportion nition of Smo by their antibody. Each study is self-con-
of Ci-155 in the nucleus and its potency as a transcrip- sistent but the different behavior of tagged smo trans-
tional activator. The majority of Ci-155 is cytoplasmic, genes clearly requires a future explanation.
even in Hh-stimulated cells, and is complexed to several All three groups agree that expression of relatively
genetically identified components of the Hh signaling large amounts of smo mRNA from transgenes does not
pathway. These include the kinesin-related molecule, readily induce ectopic Hh signal transduction. In other
Costal-2, which restricts Ci-155 activity in the absence words, Ptc and Hh appear to be able to regulate Smo
of Hh, and the protein kinase Fused, which is required activity over a very wide range of smo mRNA levels.
for normal Hh signal transduction. How a Hh signal is This prompted the novel suggestion that Ptc may act
relayed to affect the activity of Ci and its regulators is catalytically rather than stoichiometrically to repress
Smo activity (Denef et al., 2000; Ingham et al., 2000).currently a mystery. Here, I review some recent studies
A number of additional genetic and biochemical ex-concerning the first steps by which a Hh signal is trans-
periments led two groups to propose more specific,duced. These studies reveal new clues and challenge
but disparate, interpretations of the above observations.previous ideas about how Smo activity is regulated.
Alcedo et al. conclude that Smo protein levels increaseHow Does Ptc Regulate Smo Activity?
as a feedback response to Hh signaling. They suggestIt is widely stated that Ptc restricts Smo activity in un-
that this, together with the previously documented acti-stimulated cells through a binding interaction, and that
vation of ptc transcription by Hh, ensures that cells ad-Hh binding to Ptc causes a conformational change in
just Smo and Ptc protein levels to be responsive to Hh,the receptor complex that liberates Smo activity from
but to transduce a signal only in the continued presencethe repressive influence of Ptc (Figure 1A; Stone et al.,
of Hh. Denef et al. view increased Smo levels as second-1996). If space permits, authors also acknowledge that
ary to Hh-stimulated changes in the phosphorylation ofbinding of Ptc to Smo has been demonstrated only for
Smo, which serve primarily to activate and concentratevertebrate homologs and that binding is not necessarily
Smo at the cell surface. Denef et al. also provide moredirect because it was observed only in the context of
evidence that active Smo is not in a complex with Ptc,other cellular proteins. The possibility that Hh dissoci-
and specifically suggest that Ptc represses Smo activity
indirectly by regulating Smo dephosphorylation. Let us
examine the data that led to these different views.* E-mail: ddk1@columbia.edu
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Figure 1. Models for Regulation of Smo Ac-
tivity by Ptc and Hh
(A) Ptc directly inhibits Smo activity and Hh
induces a conformational change within a
Ptc/Smo complex.
(B) Hh activates Smo by causing dissociation
of a Ptc/Smo complex.
(C) Ptc inhibits Smo activity through a diffus-
ible intermediate; Hh binding to Ptc alters the
activity of this intermediate.
(D) A Ptc-associated enzyme (perhaps a ki-
nase or phosphatase) inactivates Smo within
a Ptc/Smo complex but does so catalytically,
following dissociation or degradation of Smo.
Hh binding dissociates Smo from Ptc and the
associated enzyme.
Is Modulation of Smo Protein Levels tion. Second, PKA acts directly on Ci-155 to promote
its proteolysis, and the major effect of PKA inhibitiona Feedback Response?
Two reports show that the major direct transcriptional on Hh signaling is to stabilize Ci-155 (Aza-Blanc and
Kornberg, 1999). Stabilized Ci-155 cannot, however, ac-effector of Hh signaling, Ci, is not required for Ptc to
reduce Smo protein levels, or for Hh to increase Smo count for the elevation of Smo levels by Hh since this
does not require Ci activity. These arguments do notprotein levels (Alcedo et al., 2000; Denef et al., 2000).
Thus, regulation of Smo protein levels does not depend refute the idea that cytoplasmic activation of the Hh
signaling pathway might promote Smo protein accumu-on induction of Hh-target genes. Alcedo et al. also pose
the important question of whether Smo activity is re- lation, but they do suggest that PKA inhibition affects
Smo protein levels by different means.quired in order for Hh to increase Smo protein levels.
They found that the levels of Smo protein encoded by Smo Phosphorylation and Surface Accumulation
Two potentially crucial observations made by Denef eteach of three inactive smo alleles were extremely low
and were not discernibly responsive to Hh signaling. al. provide further insight into the regulation of Smo
protein levels and activity. Both are derived from studiesThe authors deduce from this result that increased Smo
protein levels are a consequence of active signaling in S2 and Clone-8 Drosophila tissue culture cells, but
some corroborating evidence suggests that similar re-by Smo, and therefore represent a feedback response.
However, the Smo proteins encoded by the mutant al- sponses might be found in wing discs. Clone-8 cells are
derived from imaginal discs and recapitulate severalleles may all be intrinsically unstable, potentially negat-
ing this interpretation, as the authors acknowledge. It characteristics of Hh signaling in intact tissues (Chen et
al., 1999). First, Denef et al. showed that Hh signalingwould be extremely interesting to investigate this fur-
ther, perhaps using epitope-tagged versions of these stimulated accumulation of Smo protein in a more highly
phosphorylated form that migrated more slowly in SDSaltered Smo proteins in wild-type embryos to see if they
can be stabilized in trans by some aspect of Hh signal- gels. Since multiple bands of Smo were detected on
Western blots, it is likely that Smo can undergo phos-ing. Conversely, embryos lacking Fused activity might
be used to test if a component presumed to be down- phorylation at several different sites. Second, they show
that Hh signaling promotes a redistribution of Smo pro-stream of Smo in the Hh signal transduction pathway is
required for Hh to increase Smo protein levels. tein, leading to its accumulation primarily at the cell
surface, as detected by accessibility to surface biotiny-Alcedo et al. also present the observation that inhibi-
tion of protein kinase A (PKA) leads to greatly increased lation in intact cells. Surface Smo levels increased sev-
eral-fold over the course of 60 min in response to Hh,Smo protein levels in embryos. It is known that PKA
inhibition in wing discs can induce Hh-target gene ex- while total Smo protein levels were relatively unchanged.
Furthermore, it was the hyperphosphorylated forms ofpression, even in the absence of Hh and Smo. Alcedo
et al. view PKA inhibition as simulating some aspects Smo that accumulated at the surface. The authors sug-
gest enhanced transport of Smo to the surface or stabili-of the normal Hh signaling process downstream of any
interactions among Hh, Ptc, and Smo at the plasma zation of surface Smo as equally feasible explanations
of these observations. There are a couple of reasonsmembrane, and therefore conclude that Smo protein
levels depend on the activity of the Hh signaling path- why conservative modelers might prefer the second ex-
planation. First, in the long-term, Hh increases total Smoway. However, there are some problems with this line
of argument. First, high Smo levels were observed by protein levels, even in the presence of cycloheximide
(Denef et al. 2000), suggesting that Hh does stabilizeAlcedo et al. in all cells with reduced PKA activity regard-
less of their proximity to a source of Hh. By contrast, Smo protein. Of course, the transport model can be
modified to include obligatory degradation of Smo thatinhibition of PKA does not activate Hh-target gene ex-
pression in cells distant from a Hh source in embryos of fails to reach the surface. Hence, more efficient transport
could increase the half-life of Smo. Second, if Smo isthe same genetic constitution (Ohlmeyer and Kalderon,
1997). Thus, PKA inhibition produces high levels of Smo activated locally by binding of Hh to a Ptc/Smo receptor
complex at the plasma membrane, as prior dogma holds,even in the absence of productive Hh signal transduc-
Minireview
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Another recent paper investigating the function of dif-
ferent domains of Ptc provides more data for discussion
(Johnson et al., 2000). Johnson et al. could not detect a
significant binding interaction between Drosophila Smo
and Ptc in S2 cells. However, they did find that a car-
boxy-terminal truncation derivative of Ptc exhibited
dominant-negative activity. This activity might most eas-
ily be explained if this Ptc derivative associates with
Smo but does not inactivate Smo, perhaps because of
failure to recruit a cofactor that mediates the inhibitoryFigure 2. Hh-Induced Changes in Distribution of Smo and Ptc Pro-
action of Ptc. However, other explanations have notteins
been ruled out.In the absence of Hh, Ptc is likely in excess of Smo at the cell
What Determines Smo Activity?surface. Hh binding leads to increased ptc transcription and an
acute reduction in surface Ptc levels, perhaps due to endocytosis Regardless of the status of Smo/Ptc associations, we
of Hh/Ptc complexes and increased surface Smo levels. It is not now have to consider which, if any, of the newly found
clear if Smo levels ever exceed those of Ptc, or when Smo is com- responses of Smo to Hh actually determine Smo signal-
plexed to Ptc at the cell surface.
ing activity. As there really are no definitive data to guide
us here, I will take the opportunity to discuss some possi-
then Hh must initially affect a process at the plasma bilities. Although it is logical to expect that Smo activity
membrane, not on some internal membranes. However, would increase roughly in proportion to its total concen-
the old dogma is being challenged. tration, clear exceptions have already been noted in
When Is Smo in a Complex with Ptc? artificial situations where smo RNA is overproduced or
One aspect of this challenge is that surface Ptc protein PKA activity is inhibited. It is possible that in these situa-
levels were found to decrease in response to Hh signal- tions, Smo protein does not reach the plasma mem-
ing over the same time period that surface Smo levels brane, or perhaps a particular domain of the plasma
increased (Figure 2; Denef et al., 2000). If this trend were membrane, and that Smo concentration in a specific
to continue indefinitely, we would have to conclude that subcellular location is, in fact, the key determinant of
the majority of surface Smo is not in a complex with Smo activity. However, even if this is true, additional
Ptc in cells continuously exposed to Hh (Figure 1B). regulation might be expected.
However, it should be pointed out that there are no One pivotal issue is that we do not know the biochemi-
quantitative data demonstrating the relative proportions cal activity of Smo. Although its seven transmembrane
of Ptc and Smo at the cell surface in the presence or domain structure suggested that it might activate a tri-
absence of Hh. Also, during a sustained Hh response, meric G protein, there has been very little evidence sup-
transcriptional induction of ptc will lead to an acceler- porting this idea prior to a recent study of human Smo
ated rate of replenishment of Ptc protein, thereby lim- in frog melanophores (DeCamp et al., 2000). Smo activa-
iting the steady-state reduction in surface Ptc (Figure tion might nevertheless involve a conformational change
2). Thus, it is possible that Ptc protein is always present that is characteristic of G protein coupled receptors
in excess of Smo protein at the plasma membrane and (GPCRs). This idea comes from a recent study of the
that all surface Smo is in a complex with Ptc, even during locations of amino acid substitutions that constitutively
sustained Hh signaling. activate vertebrate Smo (Taipale et al., 2000). One could
The second aspect of the challenge to the old dogma easily imagine a conformational change resulting from
is much more radical. The new suggestion is that Ptc binding of Hh to a Ptc–Smo complex or from Hh-induced
may restrain the activity of Smo through a catalytic dissociation of the complex. In the case of GPCRs, this
mechanism that does not require direct contact between creates a binding site for G proteins (Bockaert and Pin,
the two molecules (Figure 1C). Regulated phosphoryla- 1999). In the case of Smo, this might create a binding
tion of Smo certainly suggests the possibility of a cata- site that links it directly to a cytoplasmic Ci effector
lytic mechanism. However, the most cogent evidence complex.
is that Smo activity remains Hh dependent even when What about Smo phosphorylation? Although increased
high-level transgene expression increases Smo protein Smo phosphorylation might result in accumulation of
levels well beyond those normally seen in cells re- active Smo at the plasma membrane (Denef et al., 2000),
sponding to Hh. Thus, Ptc appears to restrict not only such causative links have not been established. In real-
Smo protein levels, but also the specific activity of Smo ity, we might expect a more complex relationship that
protein very effectively, despite a higher presumed syn- will require tracking the status and impact of each site
thesis rate for Smo protein than for Ptc protein. An obvi- of Smo phosphorylation. One reason for expecting com-
ous weakness of this argument is that it is not quantita- plex regulation by phosphorylation is that we already
tive. This is important because Denef et al. show that it know of two kinases, PKA and Fused, involved in Hh
is possible for extremely high levels of smo expression signaling; we know that several proteins (Fused, Cos-
to activate ectopic Hh signal transduction. Thus, it is tal-2, and now Smo) become hyperphosphorylated dur-
premature to discard the idea that Ptc must bind to Smo ing Hh signaling (Ingham, 1998), and yet, there is also
in order to keep Smo activity in check. There is, however, some evidence that Hh signaling might reduce the phos-
good reason to contemplate the idea that Ptc acts catalyti- phorylation of some proteins (Chen et al., 1999). For the
cally on Smo, for example, targeting multiple Smo mole- sake of discussion, I outline below one possible model
cules for posttranslational modification or degradation for how specific kinases and phosphorylations might
regulate Hh signaling at the cell surface.through successive, transient interactions (Figure 1D).
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The role of PKA demands special attention because
Alcedo et al. have shown that Smo protein accumulates
dramatically when PKA is inhibited. There is no evidence
yet regarding the relevant target for PKA, but Smo con-
tains a cluster of putative PKA sites in its C-terminal
cytoplasmic domain. It is therefore tempting to draw a
direct analogy to similar sites in Ci and guess, as Alcedo
et al. suggest, that PKA targets Smo for degradation by
direct phosphorylation. If this occurs, Hh signaling could
lead to the accumulation of hyperphosphorylated Smo
simply by blocking degradation of PKA-phosphorylated
Smo. To complete this model I would suggest that a Ptc-
associated protein (perhaps a kinase) normally targets
PKA-phosphorylated Smo for degradation (Figure 1D),
and that Hh interrupts this process by dissociating Smo
from Ptc. Hh/Ptc complexes would be internalized and
degraded (Figure 2), limiting the movement of Hh across
cells (Chen and Struhl, 1996) and prolonging the half-
life of activated Smo roughly in proportion to Hh dose.
Liberated Smo might bring one or more associated ki-
nases to the Ci complex, leading to phosphorylation of
Costal-2 and Fused. These phosphorylations may in turn
stimulate release of Ci-155 from cytoplasmic anchorage,
association of Ci-155 with a transcriptional coactivator
and hence, movement of active Ci-155 into the nucleus.
These last ideas are, of course, highly speculative and
represent just one of many models that will be prompted
by the recent reports delving into Smo and Ptc metab-
olism.
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